Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| natural killer cell | 6 studies | 18% ± 2% | |
| epithelial cell | 5 studies | 29% ± 11% | |
| CD16-negative, CD56-bright natural killer cell, human | 3 studies | 17% ± 2% | |
| non-classical monocyte | 3 studies | 23% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 3 studies | 20% ± 2% | |
| CD8-positive, alpha-beta T cell | 3 studies | 17% ± 1% | |
| glutamatergic neuron | 3 studies | 26% ± 8% | |
| dendritic cell | 3 studies | 29% ± 2% | |
| plasmacytoid dendritic cell | 3 studies | 21% ± 3% |
Insufficient scRNA-seq data for expression of MCRS1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3049.01 | 1445 / 1445 | 100% | 47.31 | 183 / 183 |
| liver | 100% | 1567.95 | 226 / 226 | 100% | 39.81 | 406 / 406 |
| ovary | 100% | 2402.35 | 180 / 180 | 100% | 60.96 | 430 / 430 |
| pancreas | 100% | 1981.53 | 328 / 328 | 100% | 55.81 | 178 / 178 |
| skin | 100% | 2704.71 | 1809 / 1809 | 100% | 62.08 | 472 / 472 |
| thymus | 100% | 4124.07 | 653 / 653 | 100% | 76.33 | 605 / 605 |
| uterus | 100% | 3163.00 | 170 / 170 | 100% | 71.01 | 459 / 459 |
| brain | 100% | 2477.79 | 2639 / 2642 | 100% | 71.38 | 705 / 705 |
| kidney | 100% | 3321.78 | 89 / 89 | 100% | 53.58 | 898 / 901 |
| lung | 100% | 2564.26 | 578 / 578 | 100% | 58.15 | 1151 / 1155 |
| intestine | 100% | 3149.11 | 966 / 966 | 100% | 69.28 | 525 / 527 |
| breast | 100% | 2657.11 | 459 / 459 | 100% | 57.82 | 1113 / 1118 |
| prostate | 100% | 3555.38 | 245 / 245 | 99% | 59.10 | 499 / 502 |
| stomach | 100% | 2583.64 | 359 / 359 | 99% | 58.87 | 284 / 286 |
| adrenal gland | 100% | 2925.53 | 258 / 258 | 99% | 49.50 | 228 / 230 |
| bladder | 100% | 2947.48 | 21 / 21 | 99% | 67.20 | 499 / 504 |
| adipose | 100% | 2349.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 61.61 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 80.18 | 29 / 29 |
| muscle | 100% | 2727.45 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 3524.47 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 66.62 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 27.06 | 1 / 1 |
| blood vessel | 100% | 2531.94 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 3979.56 | 860 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 98% | 2230.60 | 906 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006281 | Biological process | DNA repair |
| GO_0045995 | Biological process | regulation of embryonic development |
| GO_0045739 | Biological process | positive regulation of DNA repair |
| GO_0006282 | Biological process | regulation of DNA repair |
| GO_0060382 | Biological process | regulation of DNA strand elongation |
| GO_1904507 | Biological process | positive regulation of telomere maintenance in response to DNA damage |
| GO_0006338 | Biological process | chromatin remodeling |
| GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
| GO_0036211 | Biological process | protein modification process |
| GO_0000723 | Biological process | telomere maintenance |
| GO_0033044 | Biological process | regulation of chromosome organization |
| GO_0006310 | Biological process | DNA recombination |
| GO_0006275 | Biological process | regulation of DNA replication |
| GO_1904751 | Biological process | positive regulation of protein localization to nucleolus |
| GO_0051726 | Biological process | regulation of cell cycle |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0005730 | Cellular component | nucleolus |
| GO_0044545 | Cellular component | NSL complex |
| GO_0071339 | Cellular component | MLL1 complex |
| GO_0043204 | Cellular component | perikaryon |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0030425 | Cellular component | dendrite |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0000123 | Cellular component | histone acetyltransferase complex |
| GO_0031011 | Cellular component | Ino80 complex |
| GO_0005634 | Cellular component | nucleus |
| GO_0034046 | Molecular function | poly(G) binding |
| GO_0008266 | Molecular function | poly(U) RNA binding |
| GO_0002151 | Molecular function | G-quadruplex RNA binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MCRS1 |
| Protein name | Microspherule protein 1 Microspherule protein 1 (58 kDa microspherule protein) (Cell cycle-regulated factor p78) (INO80 complex subunit J) (MCRS2) Alternative protein MCRS1 |
| Synonyms | MSP58 INO80Q |
| Description | FUNCTION: Modulates the transcription repressor activity of DAXX by recruiting it to the nucleolus . As part of the NSL complex it may be involved in acetylation of nucleosomal histone H4 on several lysine residues . Putative regulatory component of the chromatin remodeling INO80 complex which is involved in transcriptional regulation, DNA replication and probably DNA repair. May also be an inhibitor of TERT telomerase activity . Binds to G-quadruplex structures in mRNA . Binds to RNA homomer poly(G) and poly(U) . . |
| Accessions | L8E8H6 ENST00000553173.5 F8VZC2 ENST00000548646.5 F8W0I9 H0YI67 ENST00000357123.8 [Q96EZ8-2] ENST00000546244.5 [Q96EZ8-4] F8VP44 ENST00000549528.1 ENST00000548602.5 ENST00000551598.5 ENST00000548334.5 F8W126 F8VVA6 Q96EZ8 ENST00000548596.5 ENST00000550165.5 [Q96EZ8-1] ENST00000343810.9 [Q96EZ8-1] H0YIA0 |